Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITAPP: Tdap Acceptance for Non-birthing Partners
NCT06135636Phase 4Recruiting
- Sponsor
- Women & Infants Hospital
- Start
- May 2024
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Women & Infants Hospital. Primary endpoint: Tdap vaccination rate for non-birthing partners. Started May 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06135636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06135636.